774 related articles for article (PubMed ID: 2472412)
1. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
Mioh H; Chen JK
J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta inhibits the platelet-derived growth factor-induced formation of inositol trisphosphate in MG-63 human osteosarcoma cells.
Pontbriant CM; Chen JK; Orlando JA
J Cell Physiol; 1990 Dec; 145(3):488-95. PubMed ID: 1703169
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 inhibitory effect of platelet-derived growth factor-induced signal transduction on human bone marrow fibroblasts: possible involvement of protein phosphatases.
Fontenay M; Bryckaert M; Tobelem G
J Cell Physiol; 1992 Sep; 152(3):507-19. PubMed ID: 1324246
[TBL] [Abstract][Full Text] [Related]
5. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
Coffey RJ; Leof EB; Shipley GD; Moses HL
J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation.
Taverna D; Groner B; Hynes NE
Cell Growth Differ; 1991 Mar; 2(3):145-54. PubMed ID: 1676295
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
9. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation.
Russell WE
J Cell Physiol; 1988 May; 135(2):253-61. PubMed ID: 3259581
[TBL] [Abstract][Full Text] [Related]
11. Evidence for functional platelet-derived growth factor receptors on MG-63 human osteosarcoma cells.
Graves DT; Antoniades HN; Williams SR; Owen AJ
Cancer Res; 1984 Jul; 44(7):2966-70. PubMed ID: 6327031
[TBL] [Abstract][Full Text] [Related]
12. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta.
Nugent MA; Lane EA; Keski-Oja J; Moses HL; Newman MJ
Cancer Res; 1989 Jul; 49(14):3884-90. PubMed ID: 2786745
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration.
Kan M; Huang JS; Mansson PE; Yasumitsu H; Carr B; McKeehan WL
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7432-6. PubMed ID: 2477840
[TBL] [Abstract][Full Text] [Related]
14. Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor.
Tzanakakis GN; Karamanos NK; Hjerpe A
Exp Cell Res; 1995 Sep; 220(1):130-7. PubMed ID: 7664829
[TBL] [Abstract][Full Text] [Related]
15. Growth promoting activity of PDGF, EGF and TGF-beta on highly metastatic subline of Meth A cells.
Niitsu Y; Koshida Y; Mahara K; Ishigaki S; Kogawa K; Watanabe N; Urushizaki Y; Kohgo Y; Urushizaki I
Immunopharmacol Immunotoxicol; 1988; 10(1):67-78. PubMed ID: 3258877
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid differentially affects platelet-derived growth factor and epidermal growth factor-regulated cell growth of mouse osteoblast-like cells.
Tsukamoto T; Matsui T; Takaishi T; Ito M; Fukase M; Chihara K
Cell Growth Differ; 1994 Feb; 5(2):207-12. PubMed ID: 8180134
[TBL] [Abstract][Full Text] [Related]
18. Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin.
Fayed YM; Tsibris JC; Langenberg PW; Robertson AL
Lab Invest; 1989 Jan; 60(1):30-7. PubMed ID: 2536127
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 modulates phosphorylation of proteins in human osteoblastic cells.
Kang YM; Yeh YL; Graves DT
J Bone Miner Res; 1995 Jan; 10(1):96-105. PubMed ID: 7747636
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta modulates proliferation of osteoblastic cells: relation to its effect on receptor levels for epidermal growth factor.
Uneno S; Yamamoto I; Yamamuro T; Okumura H; Ohta S; Lee K; Kasai R; Konishi J
J Bone Miner Res; 1989 Apr; 4(2):165-71. PubMed ID: 2728921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
